IGF-1 LR3 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
IGF-1 LR3 is administered via subcutaneous injection (intramuscular for localized effect) at 20-100 mcg daily; conservative protocols use 20-40 mcg once daily, typically post-workout. Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject IGF-1 LR3?
IGF-1 LR3 is administered via subcutaneous injection (intramuscular for localized effect). For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Growth factor analog, IGF-1 receptor agonist compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a IGF-1 LR3 Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the IGF-1 LR3 vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our IGF-1 LR3 reconstitution guide.
Step 3: Draw your dose (20-100 mcg daily; conservative protocols use 20-40 mcg) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for IGF-1 LR3): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous IGF-1 LR3 injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your IGF-1 LR3 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for IGF-1 LR3.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on IGF-1 LR3 Injection
IGF-1 LR3 is administered via subcutaneous injection (intramuscular for localized effect) at 20-100 mcg daily; conservative protocols use 20-40 mcg once daily, typically post-workout. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
IGF-1 LR3 : Dosing, Mechanisms & Research
Related Reading
- IGF-1 LR3 Dosage Guide
- IGF-1 LR3 Benefits
- IGF-1 LR3 Side Effects
- IGF-1 LR3 Stacking Guide
- IGF-1 LR3 Cycle Guide
- IGF-1 LR3 Research
Research-Grade Sourcing
If you're going to research IGF-1 LR3, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a Growth factor analog, IGF-1 receptor agonist. Synthetic analog of endogenous IGF-1 with arginine extension and leucine substitution increasing half-life 20-30x over native IGF-1. It is researched for rapid muscle growth, accelerated recovery, bone density increase, tendon healing, neurological protection, localized anabolic effect at injection site.
What is the recommended IGF-1 LR3 dosage?
Common dosages: 20-100 mcg daily; conservative protocols use 20-40 mcg administered once daily, typically post-workout via subcutaneous injection (intramuscular for localized effect). Cycle length: 4-8 weeks maximum to prevent receptor desensitization and insulin resistance. Half-life: 20-30 hours (vs. ~15 minutes for native IGF-1). Use our peptide calculator for exact reconstitution math.
What are the side effects of IGF-1 LR3?
Hypoglycemia is the most critical risk (shakiness, sweating, confusion, potential loss of consciousness). Insulin resistance with prolonged use. Fluid retention, headaches, joint stiffness, carpal tunnel syndrome. Theoretical cancer risk through mitogenic effects at supraphysiological doses. Acromegalic changes possible with chronic abuse.
Is IGF-1 LR3 safe?
IGF-1 LR3 has shown a preliminary safety profile in research. Not FDA-approved. WADA prohibited at all times with no Therapeutic Use Exemption pathway. Classified as research reagent. All research should follow appropriate safety protocols.